|
|
||||||||
Nephrology Unit, Department of Medicine, University of Rochester School of Medicine, Rochester, New York 14642
| |
ABSTRACT |
|---|
|
|
|---|
Chronic metabolic
acidosis induces net calcium efflux from bone mineral through an
increase in osteoclastic resorption and a decrease in osteoblastic
matrix deposition and mineralization. To determine the effects of
chronic metabolic acidosis on the expression of genes necessary for
mineralization, we grew primary bone cells, which are principally
osteoblasts, to confluence in neutral pH (7.5) medium and then switched
the cells either to a neutral pH or to an acidic pH (7.1)
differentiation medium. Cells were harvested for RNA at 4- to 7-day
intervals for up to 44 days. By 36 days, there was extensive bone
nodule formation and mineralization in cells cultured in neutral
medium; however, there was a substantial decrease in nodule formation
and mineralization in cells cultured in acidic medium. There was a
marked increase in matrix Gla protein RNA and an increase in
osteopontin RNA in neutral cultures; however, acidic medium almost
completely prevented any increase. In contrast, RNA levels for
osteonectin and transforming growth factor-
1 were not altered by
chronic acidosis. Additional cells were incubated in acid
differentiation medium for 1, 2, or 3 wk and then transferred to
neutral medium; in each case, there was recovery of matrix Gla protein
RNA and osteopontin RNA expression. Still other cells were incubated in
neutral differentiation medium for 1, 2, or 3 wk and then transferred
to acid medium; in each case there was inhibition of matrix Gla protein
RNA and osteopontin RNA expression. Thus metabolic acidosis appears to specifically inhibit RNA accumulation of certain genes whose products may be essential for formation of mature bone matrix.
calcium; bone; hydrogen ion; mineralization
| |
INTRODUCTION |
|---|
|
|
|---|
IN MAMMALS, endogenous production of metabolic acids, in excess of renal excretory capacity, leads to a fall in systemic pH and consumption of proton buffers (9). These buffers include extracellular fluid bicarbonate as well as the carbonates and phosphates in bone (9, 32). During chronic metabolic acidosis, urine calcium excretion increases with no change in intestinal calcium absorption (31). To maintain systemic calcium concentration, calcium must be released from the mineral phases of bone, as greater than 98% of total body calcium resides within bone mineral (44). Thus during chronic metabolic acidosis, the bone mineral both buffers the increase in extracellular proton concentration and is the source of the additional urinary calcium. Clinical studies have demonstrated that bone is significantly affected during chronic metabolic acidosis, resulting either from the acid generated by dietary protein intake (31, 41) or from the inability to excrete protons during renal failure (9).
We have modeled the effects of metabolic acidosis on bone using
cultured neonatal mouse calvariae (6-8, 10-16, 30). There is
net efflux of calcium from cultured calvariae incubated in physiologically acidic medium produced by a decrease in bicarbonate concentration at constant partial pressure of carbon dioxide, a model
of metabolic acidosis (8, 17). During acute incubations (
24 h) in
acidic medium, physicochemical mineral dissolution is the predominant
mechanism for the calcium loss (17). However, over longer periods of
time (>24 h), metabolic acidosis induces alterations in both
osteoblastic and osteoclastic activity (8, 30). During this chronic
metabolic acidosis, there is a decrease in calvarial collagen synthesis
as well as diminished alkaline phosphatase activity, both of which
indicate suppression of osteoblastic function. In contrast, there is
increased activity of osteoclastic
-glucuronidase during metabolic
acidosis. Conversely, chronic metabolic alkalosis increases collagen
synthesis and inhibits
-glucuronidase activity (10). These changes
in bone cell function are consistent with the observed net calcium
efflux from bone.
We have recently shown that after acute serum stimulation, the expression of specific genes in osteoblasts is dependent on medium pH (24). At a physiologically acidic pH, there was decreased expression of Egr-1 and type 1 collagen RNA compared with the expression observed at a neutral pH. In contrast, expression of c-fos, c-jun, junB, and junD RNA were not altered by incubation in acidic medium. These studies suggest that acidosis alters the expression of certain immediate early response genes.
We tested the hypothesis that chronic acidosis would alter the
expression of genes important for osteoblast function. We utilized a
model of isolated primary calvarial bone cells, which are predominantly osteoblasts and osteoblast precursors. These cells, when cultured in
the presence of
-glycerophosphate and ascorbic acid, form regions of
mineralization known as bone nodules (22). In addition, as the cells
mature and form bone nodules, they sequentially exhibit a
well-characterized pattern of gene and protein expression (43). We have
previously shown that during metabolic acidosis, the number and calcium
content of these nodules are significantly reduced (42).
In this study, we maintained isolated osteoblasts in differentiation
medium either at neutral (7.5) or reduced (7.1) pH and examined the
pattern of gene expression. We found that RNA levels for osteopontin
and matrix Gla protein were dramatically inhibited by acidic medium,
whereas there was no effect on expression of osteonectin or
transforming growth factor-
1 (TGF-
1). The acid-induced inhibition
of osteopontin and matrix Gla protein RNA is reversible by subsequent
incubation in neutral medium pH, and this acid-induced inhibition
occurs even after prolonged culture in neutral medium. These results
suggest that expression of genes important for osteoblastic function is
modulated by extracellular proton concentration.
| |
METHODS |
|---|
|
|
|---|
Cell culture. Bone cells were obtained
from the calvariae (frontal and parietal bones of the skull) of 4- to
6-day-old CD-1 mice. Mice were killed by cervical dislocation, and the
calvariae were dissected immediately and then placed in chilled HEPES.
After accumulation of 20-50 calvariae, depending on the number of
cells required, the bones were washed in saline-EDTA and then subjected to collagenase (Wako Pure Chemicals, Dallas, TX) digestion (26). The
cells released by collagenase were plated on Primaria plates (Becton-Dickinson, Lincoln Park, NJ) in DME + 15% heat-inactivated horse serum at a density of 5 × 105 cells per 100-mm dish, then
cultured at 37°C in a CO2
incubator at a partial pressure of carbon dioxide
(PCO2) of
40 mmHg. After 8 days, with medium changed every 3-4 days, the
cells reached confluence. At this point, the cells were switched to
differentiation medium (DME + 15% heat-inactivated horse serum + 10 mM
-glycerophosphate + 50 µg/ml ascorbic acid), either at neutral pH
(7.5, "N" medium) or acidic pH (7.1, "A" medium). To
closely replicate physiological conditions, only the
HCO
3/CO2
buffer system was used to control pH. The initial medium pH in the
neutral group was set at 7.5, rather than the physiological neutral pH
of 7.4, as cells in culture acidify medium due to the ongoing release of metabolic acids (7). The acidic pH of 7.1 was produced by the
addition of concentrated HCl to lower medium
HCO
3 concentration
([HCO
3]) as a model of
metabolic acidosis (7, 13).
Staining. At weekly intervals, cells on plates were washed three times in PBS, then fixed for 10 min in 7% neutral buffered Formalin (100 mM NaPO4, pH 7.2). Fixed cells were washed twice in PBS, then stained for 5 min with Alizarin Red S (1% wt/vol in water; Sigma, St. Louis, MO). To remove excess dye, the plates were washed twice with PBS then with water until the runoff appeared colorless.
Gene probes and labeling. Probes used
for analysis of RNA included the following: TGF-
1, mouse, cDNA
(generous gift of Harold Moses, Vanderbilt University, Nashville, TN)
(4); osteonectin, bovine, cDNA (generous gift of Marian Young, National
Institute of Dental Research, National Institutes of
Health) (45); osteopontin, mouse, cDNA (generous gift of
Gideon Rodan, Merck, Rahway, NJ) (37); matrix Gla protein, mouse, cDNA
(generous gift of Dr. Gerard Karsenty, Anderson Cancer Center, Houston,
TX) (29); and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), mouse,
cDNA (Ambion, Austin, TX) (23). In each case, the inserts were removed from the vector by digestion with the appropriate restriction enzyme(s)
and separated by electrophoresis on low-melting point agarose. Ethidium
bromide-stained fragments were identified by ultraviolet (UV)
transillumination, excised with a razor blade, and DNA purified from
the gel with Wizard PCR Preps (Promega, Madison, WI). Radioactive
probes were prepared by random primer extension using the Decaprime II
system (Ambion) and
[
-32P]dCTP (New
England Nuclear, Boston, MA). Unincorporated nucleotides were removed
by use of CentriSep spin columns (Princeton Separations, Adelphia, NJ).
RNA extraction and analysis. The cells were quickly scraped into a chaotropic solution (TRI-LS; Molecular Research, Cincinnati, OH), which dissociates RNA from protein complexes. RNA was purified from TRI-LS following manufacturer's modification of the protocol of Chomczynski and Sacchi (19). After ethanol precipitation, the RNA was dissolved in sterile water at a concentration of 10 µg/µl. Despite extensive mineralization in older neutral cultures, no consistent differences in bulk RNA recovery were noted. Aliquots (20 µg) were denatured in 50% formamide-6% formaldehyde by heating to 65°C for 15 min, then electrophoresed on 1% agarose in MOPS-formaldehyde buffer. Samples were routinely stained with ethidium bromide during electrophoresis to ensure the integrity of the rRNA bands. After electrophoresis, the RNA was transferred to a charged nylon membrane (Zeta Probe; Bio-Rad, Richmond, CA) by capillary blotting with 10× SSC (1× SSC = 0.15 M NaCl, 0.015 M sodium citrate). After blotting, the nucleic acid was fixed to the membrane by UV cross-linking (Stratalinker; Stratagene, La Jolla, CA). Filters were hybridized and washed according to manufacturers recommendations; prehybridization (at least 1 h) and hybridization (18-22 h) were conducted in 250 mM sodium phosphate, pH 7.2, 7% SDS, and 1 mM EDTA at 65°C. After hybridization, the spent solution was removed, and the filter(s) was washed twice in 40 mM sodium phosphate, pH 7.2, 5% SDS, and 1 mM EDTA at 65°C; then twice in 40 mM sodium phosphate, pH 7.2, 1% SDS, and 1 mM EDTA at 65°C. The washed filters were visualized and the signal was quantified by use of a PhosphorImager (Molecular Dynamics, Sunnyvale, CA). To minimize variability, the same filters were sequentially hybridized to each probe in turn. Filters were routinely stripped of probe by two 20-min washes in 0.1× SSC + 0.5% SDS and heated to 100°C, and the stripped filters were then reprobed with the next labeled cDNA, the signal was quantitated as above, and the process was repeated.
| |
RESULTS |
|---|
|
|
|---|
Mineralization. All cells were first cultured for 8 days to confluence in control medium (pH 7.5) prior to incubation in neutral (pH 7.5, N) or acidic (pH 7.1, A) differentiation medium. During incubation of the isolated bone cells in N medium, mineralization was initially detected at 29 days and progressively increased over the next 14 days to the conclusion of the study at 43 days (Fig. 1). In contrast, during incubation of the cells in A medium, mineralization was not detected at any time.
|
RNA expression. To determine the effects of continuous incubation in acidic, in comparison to neutral, medium on expression of genes important for bone mineralization, bone cells were harvested at intervals of 3-7 days after switching to differentiation medium at day 8, RNA was extracted, and levels of hybridization with specific probes were examined.
RNA levels for osteopontin increased gradually with time at neutral pH
medium; however, there was no increase in osteopontin RNA
accumulation in acidic pH medium (Fig. 2,
Northern blot; and Fig. 3, densitometry
of a different filter). In contrast, when the same filter used in Fig.
2 was probed to determine RNA levels for osteonectin and TGF-
1,
there was no difference, at any time, between the A and N samples.
|
|
RNA levels for matrix Gla protein increased substantially with time in the N medium; however, there was no increase in matrix Gla protein RNA accumulation in A medium (Fig. 4, Northern blot; and Fig. 5, densitometry of a different filter).
|
|
Recovery from acid incubation. Incubation in acidic medium could irreversibly alter the bone cells, rendering them incapable of expressing osteopontin or matrix Gla protein RNA, or the acid-induced decrease in expression could be reversible. To determine whether acid-induced inhibition was reversible, after the change to differentiation medium on day 8, cultures were incubated in A medium for 1, 2, or 3 wk. Cultures were then switched to N medium for the remainder of the experiment. Bone cells were harvested for RNA analysis weekly. Parallel cultures were maintained continuously in N or A medium, to serve as time controls.
RNA levels for matrix Gla protein and osteopontin, but not osteonectin, increased from day 8 to days 22, 29, 36, and 43 with continuous incubation in N medium (Fig. 6). Continuous incubation in A medium prevented the increase in matrix Gla protein and osteopontin RNA but did not affect osteonectin RNA levels at each time point (consistent with the results shown in Figs. 2-5).
|
When cells incubated in A medium for 1 wk were switched to N medium on day 15 (R1), there was a substantial reversal of the acid-induced inhibition of matrix Gla protein and osteopontin RNA accumulation (Fig. 6, Northern blot; Fig. 7A, quantitation of matrix Gla protein; Fig. 7B, quantitation of osteopontin). When cells incubated in A medium for 2 wk were switched to N medium on day 22 (R2), there was again a reversal of the acid-induced inhibition of matrix Gla protein and osteopontin RNA. When cells incubated in A medium for 3 wk were switched to N medium on day 29 (R3), there was a partial reversal of the acid-induced inhibition of matrix Gla protein and osteopontin RNA. As the duration of incubation in A medium increased (R1 to R2 to R3), there was a decrease in the magnitude of the subsequent accumulation of both matrix Gla protein and osteopontin RNA after switching to N medium.
|
To more closely determine the rate of recovery of matrix Gla protein and osteopontin RNA levels, after the change to differentiation medium on day 8, cultures were incubated in A medium for 2 wk. Cultures were then switched to N medium for the remainder of the experiment, and bone cells were harvested for RNA analysis on days 23, 24, 27, 29, 32, and 36. Parallel cultures were maintained continuously at N or A medium, to serve as time controls (data not shown). Matrix Gla protein RNA levels did not exhibit significant recovery until 10 days after the change to neutral medium while osteopontin RNA levels recovered within 5 days (Fig. 8).
|
Acid inhibition after neutral medium pH incubation. After initial induction of matrix Gla protein and osteopontin RNA expression by neutral pH differentiation medium, the expression may continue irreversibly, or it may be inhibitable by subsequent incubation in acid medium. To determine whether A medium could inhibit RNA expression even after induction in N differentiation medium, following the change to differentiation medium on day 8, cultures were incubated in N medium for 1, 2, or 3 wk. Cultures were then switched to A medium for the remainder of the experiment. Bone cells were harvested for RNA analysis weekly. Parallel cultures were maintained continuously at N or A medium, to serve as time controls.
RNA for matrix Gla protein and osteopontin, but not osteonectin, again increased from day 8 to days 22, 29, 36, and 43 with continuous incubation in N medium (Fig. 9). Continuous incubation in A medium again prevented the increase in matrix Gla protein and osteopontin RNA but did not affect osteonectin RNA levels at each time point illustrated.
|
When cells initially cultured in N medium for 1 wk were switched to A medium on day 15 (I1), on day 22 (I2), or on day 29 (I3), there was complete inhibition of matrix Gla protein and osteopontin RNA accumulation but not osteonectin RNA (Fig. 9).
To more closely determine the rate of inhibition of matrix Gla protein and osteopontin, after the change to differentiation medium on day 8, cultures were incubated in neutral medium for 2 wk to permit expression of matrix Gla protein and osteopontin RNA. Cultures were then switched to acidic medium for the remainder of the experiment, and bone cells were harvested for RNA analysis on days 23, 24, 25, 27, 29, and 32. Parallel cultures were maintained continuously at N or A medium, to serve as time controls (data not shown). Both matrix Gla protein and osteopontin RNA levels decreased rapidly, to less than 50% of maximal values within 3 days after medium switch (Fig. 10). Osteopontin RNA levels appeared to decrease more rapidly than matrix Gla protein RNA levels.
|
| |
DISCUSSION |
|---|
|
|
|---|
Clinically, chronic metabolic acidosis has significant effects on bone
(9, 31, 41). In organ culture, metabolic acidosis induces the release
of bone calcium, mediated acutely through physicochemical dissolution
(17) and chronically through decreased cell-mediated matrix deposition
and increased cell-mediated resorption (8, 30). Acidosis decreases
osteoblastic collagen synthesis and alkaline phosphatase release and
increases osteoclastic
-glucuronidase release (8, 30). When bone
cells, primarily osteoblasts, are placed in long-term culture in
neutral pH medium, there is substantial matrix formation with
subsequent mineralization (22); similar cultures maintained in acidic
medium exhibit substantially less mineralization (42). We now show that
although incubation of bone cells in physiologically neutral medium
upregulates RNA levels for two proteins found in mature bone matrix,
matrix Gla protein and osteopontin, incubation in acidic medium almost
totally abolishes this increase. Concurrent measurements of RNA levels for two other matrix proteins, TGF-
1 and osteonectin, were
unaffected by acid incubation. Thus a decrease in medium bicarbonate
concentration producing a decrease in medium pH, a model of
physiological metabolic acidosis (8, 17), appears to have a specific
regulatory role to inhibit RNA accumulation of certain genes.
Stimulation of matrix Gla protein RNA and osteopontin RNA is inhibited
by metabolic acidosis, whereas TGF-
1 and osteonectin are not,
indicating that the inhibition is not due to a generalized toxic effect
of protons on cells. The inhibitory effect of metabolic acidosis is
fully reversible, further evidence that the increase in proton
concentration has a regulatory role and is not simply toxic to the bone cells.
The bone cells utilized in this study are principally mature osteoblasts and osteoprogenitor cells which can be expected to mature in culture (43). Even after 4 wk in culture, matrix Gla protein RNA and osteopontin RNA were each rapidly downregulated on exposure to acid medium, indicating that even these relatively differentiated cells retain their responsiveness to pH. Further studies will be required to determine whether early, purely osteoprogenitor cells also respond to an increase in medium proton concentration.
The regulatory effect of metabolic acidosis does not appear to be
mediated simply by alterations in extracellular proton concentration. Acidosis can be produced either by decreasing the medium
[HCO
3], at a constant
PCO2, which
is a model of metabolic acidosis, or by increasing the
PCO2, at a
relatively constant
[HCO
3], which is a model
of respiratory acidosis (9). Isohydric metabolic acidosis and
respiratory acidosis have profoundly different effects on
osteoblastic function (6-8, 14, 16, 42). There is a marked
decrease in osteoblastic collagen synthesis and alkaline phosphatase
activity during metabolic acidosis, whereas these parameters of
osteoblastic activity do not change during isohydric respiratory
acidosis (8). The regulatory role of metabolic acidosis also does not
appear to be mediated solely by alterations in intracellular proton
concentration. Respiratory acidosis results in a greater increase in
intracellular proton concentration than does isohydric metabolic
acidosis, yet has no measurable effect on osteoblastic function (38).
A primary function of the osteoblast is to synthesize an extracellular
matrix that is subsequently mineralized, either spontaneously or
through a cell-mediated process (43). The premineralized bone matrix,
termed osteoid, is ~90% type 1 collagen, but also contains other
proteins including osteopontin, osteonectin, osteocalcin, matrix Gla
protein, bone sialoprotein, decorin, and biglycan (46). The function of
each of these proteins is incompletely understood. Bone sialoprotein
can initiate apatite crystal formation (28), and other matrix proteins
may also act to initiate or accelerate matrix mineralization. The
-carboxylated glutamine (Gla) residues found in osteocalcin and
matrix Gla protein are known to coordinate with ionized calcium,
suggesting a role in matrix mineralization (25). However, null mutants
for each of these genes in mice have no apparent impairment of bone
formation (20, 34). Osteocalcin knockout mice have a denser and
stronger bone than normal littermates (20), whereas matrix Gla protein
knockouts die at an early age from ectopic calcification of the aorta
and great vessels (34). These results suggest that the bone Gla
proteins act to limit or direct mineralization, rather than promote it.
Like the Gla proteins, the phosphorylated poly-Asp sequence in osteopontin is an inhibitor of apatite crystal growth (5, 28). Osteopontin is found at cement lines in living bone, where new bone and old bone join (35). Osteopontin contains GRGDS sequences, which can act as promoters of attachment and spreading of fibroblasts, osteoblasts, and osteoclasts; the RGD sequences may also trigger intracellular signaling events through interaction with integrins (39).
Several studies have shown that matrix Gla protein is produced exclusively by chondrocytes and smooth muscle cells (21, 27, 33); however, Barone and co-workers have reported its expression in primary rat osteoblast cultures (2, 3). Our study is consistent with that of Barone and co-workers in that we find substantial expression of matrix Gla protein during long-term cultures of primary mouse osteoblasts. Why others have not found expression of matrix Gla protein in bone cells remains to be determined.
Both matrix Gla protein RNA and osteopontin RNA are inhibited during incubation in acid medium, suggesting the possibility that their respective genes share regulatory motifs. Whereas the 5'-flanking sequence of mouse osteopontin is available (GenBank accession no. X51834) (36), corresponding sequences of mouse matrix Gla protein are not published. Using the 5'-flanking sequence of human matrix Gla protein (GenBank accession no. M55270) (18) and searching each for established transcription factor binding motifs, >30 potential binding sites were found in each sequence (TESS, URL is http://agave.humgen.upenn.edu/tess/index.html) (40). At this time, it is not possible to conclude which sites or combination of sites may confer the pH dependence. A sequence alignment (MEME, see Ref. 1; URL is http://www.sdsc.edu/MEME/) between these fragments indicates the presence of several repeated domains with lengths up to 43 nucleotides. The potential role of these sequences in the regulation of matrix Gla protein RNA and osteopontin RNA expression during chronic metabolic acidosis remains to be elucidated.
Previously, we have shown that induction of the immediate early response gene Egr-1 and type 1 collagen were both inhibited by acidic medium and stimulated by alkaline medium (24). In contrast, the expression of other immediate early response genes including c-fos, c-jun, junB, and junD was not appreciably altered by differences in pH. Whether the acute effects of metabolic acidosis on gene expression are related to the more chronic effects demonstrated here were not addressed in this study.
We have previously shown that incubation in acidic medium produced by
lowering the [HCO
3]
decreases bone nodule formation (42). However, in the previous study
formation of bone nodules was evident by 14 days after cells were
placed in differentiation medium, whereas in the current study nodules were not evident until day 21. This
difference in the time to first detection of nodules may be due to a
difference in culture technique. In our former study the medium was
changed every other day, whereas in the current study medium was
changed twice weekly. The more frequent addition of fresh nutrients may
have resulted in an earlier appearance of bone nodules. In our previous
study, bone nodules were detected by Von Kossa staining, whereas in the current study detection was by Alizarin Red S staining. Although both
stains detect calcium deposits, it is unclear whether there is a
difference in sensitivity of these two stains and, if so, how a
difference would alter the apparent time to nodule formation. Despite
these small differences in technique, both studies confirm that
lowering the medium pH, through a decrease in
[HCO
3], will decrease the
number of bone nodules.
Metabolic acidosis stimulates release of bone calcium through a
decrease in osteoblastic bone formation and an increase in osteoclastic
bone resorption (8, 30). In bone organ culture, osteoblastic collagen
synthesis is decreased during metabolic acidosis (8, 30) and increased
during metabolic alkalosis (10). Acute metabolic acidosis inhibits the
induction of the immediate early response gene
Egr-1 and type 1 collagen gene
expression in osteoblasts (24). We now show that chronic metabolic
acidosis reversibly inhibits accumulation of RNA encoding matrix Gla
protein and osteopontin, but not osteonectin and TGF-
1, suggesting
metabolic acidosis influences osteoblastic bone matrix production and
subsequent mineralization.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Daniel Riordon for dedicated technical assistance.
| |
FOOTNOTES |
|---|
This study was supported by National Institutes of Health Grants AR-39906 and DK-47631 (both to D. A. Bushinsky) and by a grant from the National Kidney Foundation of Upstate New York (to K. K. Frick).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests: K. K. Frick, Univ. of Rochester School of Medicine, Nephrology Unit, Dept. of Medicine, 601 Elmwood Ave., Box 675, Rochester, NY 14642.
Received 20 March 1998; accepted in final form 6 August 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bailey, T. L.,
and
C. Elkan.
Fitting a mixture model by expectation maximization to discover motifs in biopolymers.
In: Proc. Int. Conf. Intellig. Syst. Mol. Biol. 2nd. Menlo Park: AAAI Press, 1994, p. 28-36.
2.
Barone, L. M.,
M. A. Aronow,
M. S. Tassinari,
D. Conlon,
E. Canalis,
G. S. Stein,
and
J. B. Lian.
Differential effects of warfarin on mRNA levels of developmentally regulated vitamin K dependent proteins, osteocalcin, and matrix GLA protein in vitro.
J. Cell. Physiol.
160:
255-264,
1994[Medline].
3.
Barone, L. M.,
T. A. Owen,
M. S. Tassinari,
R. Bortell,
G. S. Stein,
and
J. B. Lian.
Developmental expression and hormonal regulation of the rat matrix Gla protein (MGP) gene in chondrogenesis and osteogenesis.
J. Cell. Biochem.
46:
351-365,
1991[Medline].
4.
Bascom, C. C.,
J. R. Wolfshohl,
R. J. Coffey, Jr.,
L. Madisen,
N. R. Webb,
A. R. Purchio,
R. Derynck,
and
H. L. Moses.
Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2.
Mol. Cell. Biol.
9:
5508-5515,
1989
5.
Boskey, A. L.,
M. Maresca,
W. Ullrich,
S. B. Doty,
W. T. Butler,
and
C. W. Prince.
Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel.
Bone Miner.
22:
147-159,
1993[Medline].
6.
Bushinsky, D. A.
Net proton influx into bone during metabolic, but not respiratory, acidosis.
Am. J. Physiol.
254 (Renal Fluid Electrolyte Physiol. 23):
F306-F310,
1988
7.
Bushinsky, D. A.
Net calcium efflux from live bone during chronic metabolic, but not respiratory, acidosis.
Am. J. Physiol.
256 (Renal Fluid Electrolyte Physiol. 25):
F836-F842,
1989
8.
Bushinsky, D. A.
Stimulated osteoclastic and suppressed osteoblastic activity in metabolic but not respiratory acidosis.
Am. J. Physiol.
268 (Cell Physiol. 37):
C80-C88,
1995
9.
Bushinsky, D. A.
The contribution of acidosis to renal osteodystrophy.
Kidney Int.
47:
1816-1832,
1995[Medline].
10.
Bushinsky, D. A.
Metabolic alkalosis decreases bone calcium efflux by suppressing osteoclasts and stimulating osteoblasts.
Am. J. Physiol.
271 (Renal Fluid Electrolyte Physiol. 40):
F216-F222,
1996
11.
Bushinsky, D. A.,
K. Gavrilov,
J. M. Chabala,
J. D. B. Featherstone,
and
R. Levi-Setti.
Effect of metabolic acidosis on the potassium content of bone.
J. Bone Miner. Res.
12:
1664-1671,
1997[Medline].
12.
Bushinsky, D. A.,
K. Gavrilov,
V. M. Stathopoulos,
N. S. Krieger,
J. M. Chabala,
and
R. Levi-Setti.
Effects of osteoclastic resorption on bone surface ion composition.
Am. J. Physiol.
271 (Cell Physiol. 40):
C1025-C1031,
1996
13.
Bushinsky, D. A.,
J. M. Goldring,
and
F. L. Coe.
Cellular contribution to pH-mediated calcium flux in neonatal mouse calvariae.
Am. J. Physiol.
248 (Renal Fluid Electrolyte Physiol. 17):
F785-F789,
1985
14.
Bushinsky, D. A.,
B. C. Lam,
R. Nespeca,
N. E. Sessler,
and
M. D. Grynpas.
Decreased bone carbonate content in response to metabolic, but not respiratory, acidosis.
Am. J. Physiol.
265 (Renal Fluid Electrolyte Physiol. 34):
F530-F536,
1993
15.
Bushinsky, D. A.,
and
R. J. Lechleider.
Mechanism of proton-induced bone calcium release: calcium carbonate dissolution.
Am. J. Physiol.
253 (Renal Fluid Electrolyte Physiol. 22):
F998-F1005,
1987
16.
Bushinsky, D. A.,
and
N. E. Sessler.
Critical role of bicarbonate in calcium release from bone.
Am. J. Physiol.
263 (Renal Fluid Electrolyte Physiol. 32):
F510-F515,
1992
17.
Bushinsky, D. A.,
W. Wolbach,
N. E. Sessler,
R. Mogilevsky,
and
R. Levi-Setti.
Physicochemical effects of acidosis on bone calcium flux and surface ion composition.
J. Bone Miner. Res.
8:
93-102,
1993[Medline].
18.
Cancela, L.,
C. L. Hsieh,
U. Francke,
and
P. A. Price.
Molecular structure, chromosome assignment, and promoter organization of the human matrix Gla protein gene.
J. Biol. Chem.
265:
15040-15048,
1990
19.
Chomczynski, P.,
and
N. Sacchi.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:
156-159,
1987[Medline].
20.
Ducy, P.,
C. Desbois,
B. Boyce,
G. Pinero,
B. Story,
C. Dunstan,
E. Smith,
J. Bonadio,
S. Goldstein,
C. Gundberg,
A. Bradley,
and
G. Karsenty.
Increased bone formation in osteocalcin-deficient mice.
Nature
382:
448-452,
1996[Medline].
21.
Ducy, P.,
and
G. Karsenty.
Skeletal Gla proteins: gene structure, regulation of expression, and function.
In: Principles of Bone Biology, edited by J. P. Bilezikian,
L. G. Raisz,
and G. A. Rodan. San Diego: Academic, 1996, p. 183-195.
22.
Ecarot-Charrier, B.,
F. H. Glorieux,
M. Van Der Rest,
and
G. Pereira.
Osteoblasts isolated from mouse calvaria initiate matrix mineralization in culture.
J. Cell Biol.
96:
639-643,
1983
23.
Fort, P.,
L. Marty,
M. Piechaczyk,
S. El Sabrouty,
C. Dani,
P. Jeanteur,
and
J. M. Blanchard.
Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family.
Nucleic Acids Res.
13:
1431-1442,
1985
24.
Frick, K. K.,
L. Jiang,
and
D. A. Bushinsky.
Acute metabolic acidosis inhibits the induction of osteoblastic egr-1 and type 1 collagen.
Am. J. Physiol.
272 (Cell Physiol. 41):
C1450-C1456,
1997
25.
Hauschka, P. V.,
J. B. Lian,
D. E. Cole,
and
C. M. Gundberg.
Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone.
Physiol. Rev.
69:
990-1047,
1989
26.
Hefley, T. J.
Utilization of FPLC-purified bacterial collagenase for the isolation of cells from bone.
J. Bone Miner. Res.
2:
505-516,
1987[Medline].
27.
Hirakawa, K.,
S. Hirota,
T. Ikeda,
A. Yamaguchi,
T. Takemura,
J. Nagoshi,
S. Yoshiki,
T. Suda,
Y. Kitamura,
and
S. Nomura.
Localization of the mRNA for bone matrix proteins during fracture healing as determined by in situ hybridization.
J. Bone Miner. Res.
9:
1551-1557,
1994[Medline].
28.
Hunter, G. K.,
and
H. A. Goldberg.
Nucleation of hydroxyapatite by bone sialoprotein.
Proc. Natl. Acad. Sci. USA
90:
8562-8565,
1993
29.
Ikeda, T.,
A. Yamaguchi,
T. Icho,
N. Tsuchida,
and
S. Yoshiki.
cDNA and deduced amino acid sequence of mouse matrix gla protein: one of five glutamic acid residues potentially modified to gla is not conserved in the mouse sequence.
J. Bone Miner. Res.
6:
1013-1017,
1991[Medline].
30.
Krieger, N. S.,
N. E. Sessler,
and
D. A. Bushinsky.
Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro.
Am. J. Physiol.
262 (Renal Fluid Electrolyte Physiol. 31):
F442-F448,
1992
31.
Lemann, J., Jr.,
N. D. Adams,
and
R. W. Gray.
Urinary calcium excretion in human beings.
N. Engl. J. Med.
301:
535-541,
1979[Medline].
32.
Lemann, J., Jr.,
J. R. Litzow,
and
E. J. Lennon.
The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis.
J. Clin. Invest.
45:
1608-1614,
1966.
33.
Luo, G.,
R. D'Souza,
D. Hogue,
and
G. Karsenty.
The matrix Gla protein gene is a marker of the chondrogenesis cell lineage during mouse development.
J. Bone Miner. Res.
10:
325-334,
1995[Medline].
34.
Luo, G.,
P. Ducy,
M. D. McKee,
G. J. Pinero,
E. Loyer,
R. R. Behringer,
and
G. Karsenty.
Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein.
Nature
386:
78-81,
1997[Medline].
35.
McKee, M. D.,
and
A. Nanci.
Osteopontin: an interfacial extracellular matrix protein in mineralized tissues.
Connect. Tissue Res.
35:
197-205,
1996[Medline].
36.
Miyazaki, Y.,
M. Setoguchi,
S. Yoshida,
Y. Higuchi,
S. Akizuki,
and
S. Yamamoto.
The mouse osteopontin gene. Expression in monocytic lineages and complete nucleotide sequence.
J. Biol. Chem.
265:
14432-14438,
1990
37.
Noda, M.,
R. L. Vogel,
D. M. Hasson,
and
G. A. Rodan.
Leukemia inhibitory factor suppresses proliferation, alkaline phosphatase activity, and type I collagen messenger ribonucleic acid level and enhances osteopontin mRNA level in murine osteoblast-like (MC3T3E1) cells.
Endocrinology
127:
185-190,
1990[Abstract].
38.
Ori, Y.,
S. G. Lee,
N. S. Krieger,
and
D. A. Bushinsky.
Osteoblastic intracellular pH and calcium in metabolic and respiratory acidosis.
Kidney Int.
47:
1790-1796,
1995[Medline].
39.
Ross, F. P.,
J. Chappel,
J. I. Alvarez,
D. Sander,
W. T. Butler,
M. C. Farach-Carson,
K. A. Mintz,
P. G. Robey,
S. L. Teitelbaum,
and
D. A. Cheresh.
Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin
v
3 potentiate bone resorption.
J. Biol. Chem.
268:
9901-9907,
1993
40.
Schug, J.,
and
G. C. Overton.
TESS: Transcription Element Search Software on the WWW.
In: Technical Report CBIL-TR-1997-1001-v.0.0 of the Computational Biology and Informatics Laboratory, School of Medicine, University of Pennsylvania, 1997.
41.
Sebastian, A.,
S. T. Harris,
J. H. Ottaway,
K. M. Todd,
and
R. C. Morris, Jr.
Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate.
N. Engl. J. Med.
330:
1776-1781,
1994
42.
Sprague, S. M.,
N. S. Krieger,
and
D. A. Bushinsky.
Greater inhibition of in vitro bone mineralization with metabolic than respiratory acidosis.
Kidney Int.
46:
1199-1206,
1994[Medline].
43.
Stein, G. S.,
J. B. Lian,
J. L. Stein,
A. J. vanWijnen,
and
M. Montecino.
Transcriptional control of osteoblast growth and differentiation.
Physiol. Rev.
76:
593-629,
1996
44.
Widdowson, E.,
and
M. Dickerson.
Chemical composition of the body.
In: Mineral Metabolism, edited by C. L. Comar,
and F. Bronner. New York: Academic, 1964, p. 1-247.
45.
Young, M. F.,
M. E. Bolander,
A. A. Day,
C. I. Ramis,
P. G. Robey,
Y. Yamada,
and
J. D. Termine.
Osteonectin mRNA: distribution in normal and transformed cells.
Nucleic Acids Res.
14:
4483-4497,
1986
46.
Young, M. F.,
J. M. Kerr,
K. Ibaraki,
A. M. Heegaard,
and
P. G. Robey.
Structure, expression, and regulation of the major noncollagenous matrix proteins of bone.
Clin. Orth. Rel. Res.
281:
275-294,
1992.
This article has been cited by other articles:
![]() |
K. K. Frick, K. LaPlante, and D. A. Bushinsky RANK ligand and TNF-{alpha} mediate acid-induced bone calcium efflux in vitro Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1005 - F1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Bushinsky, S. B. Smith, K. L. Gavrilov, L. F. Gavrilov, J. Li, and R. Levi-Setti Chronic acidosis-induced alteration in bone bicarbonate and phosphate Am J Physiol Renal Physiol, September 1, 2003; 285(3): F532 - F539. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Bushinsky, S. B. Smith, K. L. Gavrilov, L. F. Gavrilov, J. Li, and R. Levi-Setti Acute acidosis-induced alteration in bone bicarbonate and phosphate Am J Physiol Renal Physiol, November 1, 2002; 283(5): F1091 - F1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Greenwald, B. J. Mehrara, J. A. Spector, S. M. Warren, P. J. Fagenholz, L. P. Smith, P. J. Bouletreau, F. E. Crisera, H. Ueno, and M. T. Longaker In Vivo Modulation of FGF Biological Activity Alters Cranial Suture Fate Am. J. Pathol., February 1, 2001; 158(2): 441 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Spector, B. J. Mehrara, J. A. Greenwald, P. B. Saadeh, D. S. Steinbrech, P. J. Bouletreau, L. P. Smith, and M. T. Longaker Osteoblast expression of vascular endothelial growth factor is modulated by the extracellular microenvironment Am J Physiol Cell Physiol, January 1, 2001; 280(1): C72 - C80. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Krieger, W. R. Parker, K. M. Alexander, and D. A. Bushinsky Prostaglandins regulate acid-induced cell-mediated bone resorption Am J Physiol Renal Physiol, December 1, 2000; 279(6): F1077 - F1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Frick and D. A. Bushinsky In vitro metabolic and respiratory acidosis selectively inhibit osteoblastic matrix gene expression Am J Physiol Renal Physiol, November 1, 1999; 277(5): F750 - F755. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Bushinsky, J. M. Chabala, K. L. Gavrilov, and R. Levi-Setti Effects of in vivo metabolic acidosis on midcortical bone ion composition Am J Physiol Renal Physiol, November 1, 1999; 277(5): F813 - F819. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Bushinsky, W. R. Parker, K. M. Alexander, and N. S. Krieger Metabolic, but not respiratory, acidosis increases bone PGE2 levels and calcium release Am J Physiol Renal Physiol, December 1, 2001; 281(6): F1058 - F1066. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||